Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
Clinical trial NCT02203903 · RECRUITING
Trial details
- NCT number
- NCT02203903
- Sponsor
- Catherine Bollard
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-02
- Primary completion
- 2026-11-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.